PE20000860A1 - Composiciones mucoadhesivas orales que contienen activos gastrointestinales - Google Patents

Composiciones mucoadhesivas orales que contienen activos gastrointestinales

Info

Publication number
PE20000860A1
PE20000860A1 PE1999000852A PE00085299A PE20000860A1 PE 20000860 A1 PE20000860 A1 PE 20000860A1 PE 1999000852 A PE1999000852 A PE 1999000852A PE 00085299 A PE00085299 A PE 00085299A PE 20000860 A1 PE20000860 A1 PE 20000860A1
Authority
PE
Peru
Prior art keywords
gum
composition
gastrointestinal
clay
assets
Prior art date
Application number
PE1999000852A
Other languages
English (en)
Inventor
Douglas Joseph Dobrozsi
Todd Ehren Vienneau
Christopher Mayer
Kishorkumar Jivanlal Desai
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE20000860A1 publication Critical patent/PE20000860A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA COMPOSICION LIQUIDA ACUOSA MUCOADHESIVA ORAL O PERORAL QUE COMPRENDE: a)UN PRINCIPIO ACTIVO GASTROINTESTINAL TAL COMO SALES DE BISMUTO; b)DE 1,5% A 10% DE ARCILLA O DE 2% A 50% DE UN COMPONENTE DE PARTICULAS TAL COMO DIOXIDO DE TITANIO O DIOXIDO DE SILICONA; c)DE 0,01% A 1% DE GOMA SELECCIONADO DE GOMA DE XANTANO, GOMA DE GUAR, GOMA DE ALGARROBO, CARRAGENANOS, TRAGACANTO, CARBOMERO. d)UN COMPONENTE NO IONICO DE PREFERENCIA METILCELULOSA, ETILCELULOSA, HIDROXIETILCELULOSA, HIDROXIPROPILCELULOSA, HIDROXIPROPILMETILCELULOSA, POLIVINILPIRROLIDONA, ENTRE OTROS. LA COMPOSICION SE CARACTERIZA POR i)UNA RELACION ENTRE LA ARCILLA Y LA GOMA DE 10:1 A 100:1; ii)UNA VISCOSIDAD A CERO ESFUERZO CORTANTE DE POR LO MENOS 2000 SEGUNDOS PASCAL; iii)UNA RELACION DE SEDIMENTACION A VOLUMEN SUPERIOR A 0,90 CUANDO SE MIDE DESPUES DE 48 HORAS; iv)UNA RELACION DE VISCOSIDAD PROVOCADA DE 1,2. LA COMPOSICION PUEDE SER UTIL PARA RECUBRIR EL TRACTO GASTROINTESTINAL Y TRATAR TRASTORNOS GASTROINTESTINALES COMO NAUSEA, ACIDEZ, DIARREA
PE1999000852A 1998-08-24 1999-08-24 Composiciones mucoadhesivas orales que contienen activos gastrointestinales PE20000860A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9757698P 1998-08-24 1998-08-24

Publications (1)

Publication Number Publication Date
PE20000860A1 true PE20000860A1 (es) 2000-09-11

Family

ID=22264116

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000852A PE20000860A1 (es) 1998-08-24 1999-08-24 Composiciones mucoadhesivas orales que contienen activos gastrointestinales

Country Status (15)

Country Link
US (1) US20010016577A1 (es)
EP (1) EP1115378A1 (es)
JP (1) JP2002523352A (es)
KR (1) KR20010072463A (es)
CN (1) CN1313755A (es)
AU (1) AU5685299A (es)
BR (1) BR9913227A (es)
CA (1) CA2338688A1 (es)
CO (1) CO5140071A1 (es)
HU (1) HUP0103216A2 (es)
ID (1) ID27728A (es)
NO (1) NO20010833D0 (es)
PE (1) PE20000860A1 (es)
TR (1) TR200100629T2 (es)
WO (1) WO2000010527A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801791B1 (fr) * 1999-12-03 2003-05-30 Elpronat Composition pour animaux contenant du salicylate de methyle
DK1474109T3 (da) * 2001-12-21 2010-10-25 Alcon Inc Anvendelse af syntetiske uorganiske nanopartikler som bærere af ophthalmiske lægemidler
CA2500218A1 (en) * 2002-09-26 2004-04-08 Yamanouchi Pharmaceutical Co., Ltd. Drug absorptivity improving agent
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP2011503073A (ja) 2007-11-13 2011-01-27 メリテイジ ファーマ,インク. コルチコステロイド組成物
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
JP5281715B2 (ja) * 2009-08-05 2013-09-04 コヴィディエン リミテッド パートナーシップ 内部に埋め込まれた電極を有する接続ハイドロゲルビードを組み込む外科用創傷被覆
EP2386289A1 (en) * 2010-04-29 2011-11-16 Ipsen Pharma S.A.S. Clay compositions
US11147751B2 (en) * 2010-12-23 2021-10-19 Colgate-Palmolive Company Fluid compositions comprising a structuring agent
RU2609862C2 (ru) 2011-12-15 2017-02-06 Колгейт-Палмолив Компани Водные композиции по уходу за полостью рта
US20140178456A1 (en) * 2012-08-30 2014-06-26 Udaya Sankar Devanaboyina Methods and compositions for treating type 2 diabetes and related conditions
WO2014088534A1 (en) 2012-12-03 2014-06-12 Colgate-Palmolive Company Manufacturing processes for gellan gum-based fluid gels
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
CA2943420C (en) * 2014-04-29 2019-06-25 The Procter & Gamble Company Method for making bismuth-containing liquid pharmaceutical suspensions
AU2015253188B2 (en) * 2014-04-29 2017-09-28 The Procter & Gamble Company Bismuth-containing liquid pharmaceutical suspensions
WO2016011028A1 (en) 2014-07-14 2016-01-21 University Of Utah Research Foundation In situ solidifying complex coacervates and methods of making and using thereof
JP2017178881A (ja) * 2016-03-31 2017-10-05 小林製薬株式会社 経口組成物
JP6950312B2 (ja) * 2017-07-12 2021-10-13 ライオン株式会社 液体医薬組成物及び医薬品
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
AU2019212513A1 (en) 2018-01-26 2020-09-03 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
GB9114950D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
WO1994020074A1 (en) * 1993-03-12 1994-09-15 The Procter & Gamble Company Adsorbate compositions

Also Published As

Publication number Publication date
KR20010072463A (ko) 2001-07-31
WO2000010527A1 (en) 2000-03-02
NO20010833L (no) 2001-02-19
CN1313755A (zh) 2001-09-19
TR200100629T2 (tr) 2001-07-23
US20010016577A1 (en) 2001-08-23
AU5685299A (en) 2000-03-14
BR9913227A (pt) 2001-05-22
HUP0103216A2 (hu) 2002-01-28
CO5140071A1 (es) 2002-03-22
EP1115378A1 (en) 2001-07-18
ID27728A (id) 2001-04-26
NO20010833D0 (no) 2001-02-19
JP2002523352A (ja) 2002-07-30
CA2338688A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
PE20000860A1 (es) Composiciones mucoadhesivas orales que contienen activos gastrointestinales
DE3789533D1 (de) Verdickte, wässerige Reinigungsmittel.
ES2140444T3 (es) Composicion y procedimiento para desarrollar viscosidad extensional en composiciones limpiadoras.
ATE176381T1 (de) Organische peroxysäure enthaltende wässrige zusammensetzungen
PE20080374A1 (es) Composiciones farmaceuticas de ropinirol
TW434023B (en) Preserved ophthalmic composition
BR9910113A (pt) Composições oftálmicas que se transformam em gel, contendo goma xantano
DE69426727D1 (de) Antimikrobielle zusammensetzungen für abwischtücher
BR9812362A (pt) Formulação bucodental, utilização de nanofibrilas de celulose, e, processo para espessar uma formulação bucodental
TR200000481T2 (tr) N-Alkonoilfenilalenin türevleri.
PE20080093A1 (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana
BR0311261A (pt) Composição lìquida aquosa branqueadora dos dentes, e, método para branquear os dentes
ES2187467T3 (es) Composiciones liquidas de proteccion solar con buena deposicion y formacion de espuma.
CO5150160A1 (es) Formulacion antisudoral para aplicador poroso
ATE364677T1 (de) Wasserlösliches beutelchen mit reinigungsmittel für harte oberflächen
WO2006009679A3 (en) Oral care compositions
BR9810291A (pt) Composições antitranspirantes em bastão de gel sólido com baixa formação residual contendo solventes de hidrocarboneto não-polares voláteis
ES2184310T3 (es) Formulacion autoemulsionante para compuestos lipofilos acidos.
CO5160322A1 (es) Composiciones antiperspirantes
DK1358883T3 (da) Reepiteliserende farmaceutiske sammensætninger indeholdende xanthangummi
ATE103970T1 (de) Verdickte, waesserige reinigungsmittel.
DE59906391D1 (de) Mittel zum schutz der haut enthaltend hydrolysierte hyaluronsäure
DE10234885B4 (de) Kosmetische und/oder dermatologische Silikon-in Wasser-Emulsionen und transparentes Packmittel enthaltend diese Sonnenschutzzubereitungen
DE60225143D1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
CA2359491A1 (en) Mixture of plant treatment compositions with waxes, their preparation, and their use

Legal Events

Date Code Title Description
FD Application declared void or lapsed